Common use of Minimum Net Revenue Clause in Contracts

Minimum Net Revenue. As of the end of the fiscal quarter ended June 20, 2023, and each fiscal quarter thereafter, Parent and its Subsidiaries shall maintain, on a consolidated basis, Net Revenue for the twelve (12) month period most recently ended on such date of not less than the amount set forth in the table below: Twelve-Month Period Ended Minimum Net Revenue June 30, 2023 $83,484,000 September 30, 2023 $87,901,000 December 31, 2023 $92,305,000 March 31, 2024 $96,541,000 June 30, 2024 $100,623,000 September 30, 2024 $104,140,000 December 31, 2024 $108,238,000 March 31, 2025 $112,098,000 June 30, 2025 $115,410,000 September 30, 2025 $119,319,000

Appears in 1 contract

Samples: Credit Agreement (Trinity Biotech PLC)

AutoNDA by SimpleDocs

Minimum Net Revenue. As of the end of the fiscal quarter ended June 20December 31, 2023, and each fiscal quarter thereafter, Parent and its Subsidiaries shall maintain, on a consolidated basis, Net Revenue for the twelve (12) month period most recently ended on such date of not less than the amount set forth in the table below: Twelve-Month Period Ended Minimum Net Revenue June 30, 2023 $83,484,000 September 30, 2023 $87,901,000 December 31, 2023 $92,305,000 0 March 31, 2024 $96,541,000 53,100,000 June 30, 2024 $100,623,000 54,300,000 September 30, 2024 $104,140,000 55,700,000 December 31, 2024 $108,238,000 59,900,000 March 31, 2025 $112,098,000 62,500,000 June 30, 2025 $115,410,000 64,600,000 September 30, 2025 $119,319,00067,500,000 December 31, 2025 $69,100,000

Appears in 1 contract

Samples: Trinity Biotech PLC

Minimum Net Revenue. As of the end last day of the fiscal quarter ended June 20, 2023, and each fiscal quarter thereafterset forth below, the Parent Guarantor and its Subsidiaries shall maintainhave generated Net Revenue, on a consolidated basis, Net Revenue for the twelve (12) consecutive month period most recently ended ending on the last day of such date of fiscal quarter, in an aggregate amount not less than the corresponding amount set forth in the table belowopposite such fiscal quarter: Twelve-Month Period Ended Minimum Net Fiscal Quarter Ending Revenue September 30, 2020 $10,500,000 December 31, 2020 $16,400,000 March 31, 2021 $25,800,000 June 30, 2021 $34,900,000 September 30, 2021 $43,500,000 December 31, 2021 $49,300,000 March 31, 2022 $53,400,000 June 30, 2022 $56,600,000 September 30, 2022 $59,900,000 December 31, 2022 $64,100,000 March 31, 2023 $72,000,000 June 30, 2023 $83,484,000 80,300,000 September 30, 2023 $87,901,000 88,800,000 December 31, 2023 $92,305,000 97,000,000 March 31, 2024 $96,541,000 103,200,000 June 30, 2024 $100,623,000 September 30, 2024 $104,140,000 December 31, 2024 $108,238,000 March 31, 2025 $112,098,000 June 30, 2025 $115,410,000 September 30, 2025 $119,319,000109,500,000

Appears in 1 contract

Samples: Credit Agreement and Guaranty (Foamix Pharmaceuticals Ltd.)

Minimum Net Revenue. As of the end of the fiscal quarter ended June 20December 31, 20232021, and each fiscal quarter thereafter, Parent and its Subsidiaries shall maintain, on a consolidated basis, Net Revenue for the twelve (12) month period most recently ended on such date of not less than the amount set forth in the table below: Twelve-Month Period Ended Minimum Net Revenue December 31, 2021 $91,213,000 March 31, 2022 $82,296,000 June 30, 2022 $74,166,000 September 30, 2022 $71,413,000 December 31, 2022 $73,307,000 March 31, 2023 $78,392,000 June 30, 2023 $83,484,000 September 30, 2023 $87,901,000 December 31, 2023 $92,305,000 March 31, 2024 $96,541,000 June 30, 2024 $100,623,000 September 30, 2024 $104,140,000 December 31, 2024 $108,238,000 March 31, 2025 $112,098,000 June 30, 2025 $115,410,000 September 30, 2025 $119,319,000

Appears in 1 contract

Samples: Credit Agreement (Trinity Biotech PLC)

AutoNDA by SimpleDocs

Minimum Net Revenue. As of the end of the fiscal quarter ended June 2030, 2023, and each fiscal quarter thereafter, Parent and its Subsidiaries shall maintain, on a consolidated basis, Net Revenue for the twelve (12) month period most recently ended on such date of not less than the amount set forth in the table below: Twelve-Month Period Ended Minimum Net Revenue June 30, 2023 $83,484,000 55,800,000 September 30, 2023 $87,901,000 61,000,000 December 31, 2023 $92,305,000 67,800,000 March 31, 2024 $96,541,000 74,400,000 June 30, 2024 $100,623,000 76,900,000 September 30, 2024 $104,140,000 78,300,000 December 31, 2024 $108,238,000 78,300,000 March 31, 2025 $112,098,000 80,800,000 June 30, 2025 $115,410,000 83,200,000 September 30, 2025 $119,319,00085,700,000 December 31, 2025 $88,200,000”

Appears in 1 contract

Samples: Trinity Biotech PLC

Time is Money Join Law Insider Premium to draft better contracts faster.